VF
NMTC icon

Virtu Financial’s NeuroOne Medical Technologies NMTC Stock Holding History

Virtu Financial’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,533
Closed -$88K – 2047
2025
Q3 		$88K Buy
+16,533
New +$80.9K ﹤0.01% 1060
2024
Q4 		– Sell
-1,739
Closed -$10K – 1882
2024
Q3 		$10K Sell
1,739
-1,453
-46% -$7.27K ﹤0.01% 1202
2024
Q2 		$15K Buy
+3,192
New +$20.1K ﹤0.01% 1074
2024
Q1 		– Sell
-3,020
Closed -$29K – 1868
2023
Q4 		$29K Buy
+3,020
New +$22.2K ﹤0.01% 1262
2023
Q1 		– Sell
-2,490
Closed -$18K – 1896
2022
Q4 		$18K Buy
+2,490
New +$22.3K ﹤0.01% 1289
2022
Q2 		– Sell
-2,581
Closed -$17K – 1909
2022
Q1 		$17K Buy
+2,581
New +$31.3K ﹤0.01% 1315

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's NMTC Position: Q4 2025 in Review

Virtu Financial sold out of NeuroOne Medical Technologies (NMTC) in Q4 2025, closing a stake of 16,533 shares — an estimated $88K sold.

Virtu Financial first reported a position in NMTC in Q1 2022 and held it in 6 quarters. The position peaked at $88K in Q3 2025. 37 funds tracked by Wall St. Rank hold NMTC as of Q4 2025.

  • Virtu Financial reported no remaining NeuroOne Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 16,533 NeuroOne Medical Technologies shares in Q4 2025, an estimated $88K.
  • Virtu Financial first reported a position in NeuroOne Medical Technologies in Q1 2022 and held it in 6 quarters.
  • Virtu Financial's NeuroOne Medical Technologies position peaked at $88K in Q3 2025.
  • 37 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.